Details of Drug-Drug Interaction
| Drug General Information (ID: DDIRIMY8LK) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Sorafenib | Drug Info | Thyroid, porcine | Drug Info | |||||
| Drug Type | Small molecule | Hormones | |||||||
| Therapeutic Class | Antineoplastics | Thyroid Drugs | |||||||
| Mechanism of Sorafenib-Thyroid, porcine Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Attenuated pharmacological effects (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Sorafenib | Thyroid, porcine | |||||||
| Mechanism | Decrease the suppression effect of exogenous thyroid hormone on differentiated thyroid carcinoma | Thyroid hormone | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacodynamics | ||||||||
| Factor Description | Reduced pharmacological effects leading to insufficient efficacy and/or treatment failure. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | TSH levels should be monitored monthly during sorafenib treatment for differentiated thyroid carcinoma, and the dosage of thyroid replacement medication adjusted as necessary. | ||||||||
